Metabolic burden and disease and mortality risk associated with impaired fasting glucose in elderly adults

Journal of the American Geriatrics Society

Volumn 63, Issue 7, 2015, Pages 1435-1442

  Samaras, Katherine ^a,b   Crawford, John ^c   Lutgers, Helen L ^a   Campbell, Lesley V ^a,b   Baune, Bernhard T ^d   Lux, Ora ^e   Brodaty, Henry ^c   Trollor, Julian N ^c   Sachdev, Perminder ^c,e  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

cancer; cardiovascular disease; cholesterol; diabetes mellitus; geriatric; glucose; hypertension; impaired fasting glucose; inflammation; obesity

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; CAROTENE; CHOLESTEROL; CREATININE; CYANOCOBALAMIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; RETINOL; SERUM AMYLOID A; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URATE; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ACUTE HEART INFARCTION; AEROBIC METABOLISM; AGED; ALCOHOL CONSUMPTION; ANGINA PECTORIS; ARTICLE; BODY MASS; BODY WEIGHT; BREAST CANCER; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLAUDICATION; COLON CANCER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISCRIMINANT ANALYSIS; DISORDERS OF CARBOHYDRATE METABOLISM; EDUCATION; FEMALE; GLUCOSE BLOOD LEVEL; HALFWAY HOUSE; HEART ARRHYTHMIA; HEART DISEASE; HIGH SCHOOL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED FASTING GLUCOSE; INCIDENCE; INFLAMMATION; INSULIN BLOOD LEVEL; KIDNEY DISEASE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; NEOPLASM; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PENSIONER; PHYSICAL DISABILITY; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ANALYSIS; BLOOD; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMPLICATION; IMPAIRED GLUCOSE TOLERANCE; RISK FACTOR; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FASTING; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; MALE; OXIDATIVE STRESS; PREDIABETIC STATE; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; STROKE;

EID: 84937527087     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13482     Document Type: Article

References (26)

1. Barr EL, Zimmet PZ, Welborn TA, et al., Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007; 116: 151-157.
2. Wei M, Gaskill SP, Haffner SM, et al., Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998; 21: 1167-1172.
3. Smith U, Gale EA,. Cancer and diabetes: Are we ready for prime time? Diabetologia 2010; 53: 1541-1544.
4. Selvin E, Coresh J, Brancati FL,. The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care 2006; 29: 2415-2419.
5. Colagiuri S, Hussain Z, Zimmet P, et al., Screening for type 2 diabetes and impaired glucose metabolism: The Australian experience. Diabetes Care 2004; 27: 367-371.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-S69.
7. Barzilay JI, Spiekerman CF, Wahl PW, et al., Cardiovascular disease in older adults with glucose disorders: Comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet 1999; 354: 622-625.
8. Levitzky YS, Pencina MJ, D'Agostino RB, et al., Impact of impaired fasting glucose on cardiovascular disease: The Framingham Heart Study. J Am Coll Cardiol 2008; 51: 264-270.
9. Mazurek M, Kowalczyk J, Lenarczyk R, et al., The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively. Cardiovasc Diabetol 2012; 11: 78.
10. Rijkelijkhuizen JM, Nijpels G, Heine RJ, et al., High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: The Hoorn study. Diabetes Care 2007; 30: 332-336.
11. Yeboah J, Bertoni AG, Herrington DM, et al., Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2011; 58: 140-146.
12. Lenzen M, Ryden L, Ohrvik J, et al., Euro Heart Survey Investigators. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: A report from the Euro Heart Survey on diabetes and the heart. Eur Heart J 2006; 27: 2969-2974.
13. Ding D, Qiu J, Li X, et al., Hyperglycemia and mortality among patients with coronary artery disease. Diabetes Care 2014; 37: 546-554.
14. Cowie CC, Rust KF, Ford ES, et al., Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32: 287-294.
15. Sachdev PS, Brodaty H, Reppermund S, et al., The Sydney Memory and Ageing Study (MAS): Methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr 2010; 22: 1248-1264.
16. Samaras K, Crawford J, Baune BT, et al., The value of the Metabolic Syndrome concept in the elderly: Is its worth less than the sum of its parts? J Am Geriatr Soc 2012; 60: 1734-1741.
17. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia [on-line]. Available at http://www.idf.org/webdata/docs/WHO-IDF-definition-diagnosis-of-diabetes.pdf Accessed January 20, 2014.
18. Matthews DR, Hosker JP, Rudenski AS, et al., Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
19. Trollor JN, Smith E, Baune BT, et al., Systemic inflammation is associated with MCI and its subtypes: The Sydney Memory and Aging Study. Dement Geriatr Cogn Disord 2010; 30: 569-578.
20. Ford ES, Zhao G, Li C,. Pre-diabetes and the risk for cardiovascular disease: A systematic review of the evidence. J Am Coll Cardiol 2010; 55: 1310-1317.
21. Sui X, Lavie CJ, Hooker SP, et al., A prospective study of fasting plasma glucose and risk of stroke in asymptomatic men. Mayo Clin Proc 2011; 86: 1042-1049.
22. Barzilay JI, Spiekerman CF, Kuller LH, et al., Cardiovascular Health Study. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: The Cardiovascular Health Study. Diabetes Care 2001; 24: 1233-1239.
23. Cnop M, Igoillo-Esteve M, Hughes SJ, et al., Longevity of human islet α- and β-cells. Diabetes Obes Metab 2011; 13 (Suppl 1): 39-46.
24. Australian Burden of Disease Study: Fatal Burden of Disease in Aboriginal and Torres Strait Islander People 2010 [on-line]. Available at http://www.aihw.gov.au/ Accessed February 14, 2014.
25. Ceriello A, Assaloni R, Da Ros R, et al., Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005; 111: 2518-2524.
26. Santilli F, Formoso G, Sbraccia P, et al., Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. J Thromb Haemost 2010; 8: 828-837.